What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
Do gene mutations impact clinical outcome in elderly acute myeloid leukemia (AML) patients?
EBMT 2017: Highlighting the hottest topics in the field of transplantation
Understanding the drivers behind disease with the 100,000 Genomes Project
Treatment of minimal residual disease in AML patients